Use of bedaquiline and delamanid in diabetes patients: clinical and pharmacological considerations
Minhui Hu,1 Chunlan Zheng,1 Feng Gao2 1Department of Internal Medicine – Section 5, Wuhan Pulmonary Hospital (Wuhan Tuberculosis Control Institute), 2Department of Endocrinology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People’...
Saved in:
Main Authors: | Hu MH (Author), Zheng CL (Author), Gao F (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2016-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Rezultatele tratamentului tuberculozei multidrogrezistente cu utilizarea bedaquiline şi delamanid
by: Rafig Bayramov, et al.
Published: (2021) -
Evaluation of the effectiveness of bedaquiline and delamanid treatment among children and adolescents with multi-drug-resistant pulmonary tuberculosis
by: M.I. Sakhelashvili, et al.
Published: (2023) -
Whole Genome Sequencing for the Analysis of Drug Resistant Strains of <i>Mycobacterium tuberculosis</i>: A Systematic Review for Bedaquiline and Delamanid
by: Luisa Maria Nieto Ramirez, et al.
Published: (2020) -
The role of delamanid in the treatment of drug-resistant tuberculosis
by: Lewis JM, et al.
Published: (2015) -
Profile of delamanid for the treatment of multidrug-resistant tuberculosis
by: Szumowski JD, et al.
Published: (2015)